Boston Partners’s Allergan Inc AGN Stock Holding History

Boston Partners’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-104,600	Closed	-$13M	–	779
2014 Q1	$13M	Buy	+104,600	New	+$12.7M	0.02%	353

Other funds holding AGN

PSCM

Pershing Square Capital Management New York $19.5B AUM 2.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Boston Partners's AGN Position: Q2 2014 in Review

Boston Partners sold out of Allergan Inc (AGN) in Q2 2014, closing a stake of 104,600 shares — an estimated $13M sold.

Boston Partners first reported a position in AGN in Q1 2014 and held it in 1 quarter. The position peaked at $13M in Q1 2014. 770 funds tracked by Wall St. Rank hold AGN as of Q2 2014.

Boston Partners reported no remaining Allergan Inc position as of Q2 2014 after selling out during the quarter.
Boston Partners sold 104,600 Allergan Inc shares in Q2 2014, an estimated $13M.
Boston Partners first reported a position in Allergan Inc in Q1 2014 and held it in 1 quarter.
Boston Partners's Allergan Inc position peaked at $13M in Q1 2014.
770 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2014.

Based on Boston Partners's 13F filing for Q2 2014, filed 8 Aug 2014.